Difference between revisions of "Messersmith WA, et al. Clin. Cancer Res. (2015) cited as Ref 592 in DOI: 10.1038/s41392-020-0110-5 (Q9855)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 25231399, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Page(s) (P105): 60-67, #quickstatements; #temporary_batch_1590074839150)
 
(4 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2015
Timestamp+2015-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2015 / rank
 +
Normal rank
Property / Published In Name String
 +
Clin. Cancer Res.
Property / Published In Name String: Clin. Cancer Res. / rank
 +
Normal rank
Property / Volume
 +
21
Property / Volume: 21 / rank
 +
Normal rank
Property / title
 +
A phase I dose-finding study in patients with advanced solid malignancies of the oral gamma-secretase inhibitor PF-03084014 (English)
Property / title: A phase I dose-finding study in patients with advanced solid malignancies of the oral gamma-secretase inhibitor PF-03084014 (English) / rank
 +
Normal rank
Property / Page(s)
 +
60-67
Property / Page(s): 60-67 / rank
 +
Normal rank

Latest revision as of 15:46, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Messersmith WA, et al. Clin. Cancer Res. (2015) cited as Ref 592 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Messersmith WA
    0 references
    0 references
    2015
    0 references
    Clin. Cancer Res.
    0 references
    21
    0 references
    A phase I dose-finding study in patients with advanced solid malignancies of the oral gamma-secretase inhibitor PF-03084014 (English)
    0 references
    60-67
    0 references